Health Innovation Capital

HIC employs a pediatric-centric approach to healthcare impact investing, targeting established management teams that drive change in patient care and outcomes. The firm invests in disruptive health innovations that enhance care quality, access, affordability, and outcomes for pediatric populations. HIC's investment strategy spans various stages, including seed, Series A, Series B, and growth equity, allowing for a broad range of investment opportunities.

Geographically, HIC is agnostic, with investments in North America, Europe, and the Middle East & North Africa (MENA). The firm seeks early-stage opportunities that can demonstrate measurable improvements in pediatric care. HIC aims for upper quartile returns on invested capital compared to other healthcare venture funds, ensuring that their investments not only support innovation but also deliver financial performance.

Health Innovation Capital collaborates with renowned medical practitioners and thought leaders from over 30 healthcare centers of excellence to evaluate investment opportunities. While specific portfolio companies are not detailed in the provided content, HIC's focus on pediatric healthcare innovations spans various sectors, including therapeutics, medical technologies, and digital health. The firm’s commitment to improving pediatric healthcare outcomes is evident in its investment strategy.

Additionally, HIC's foundation plays a crucial role in supporting early-stage research and development in pediatric care, further enhancing its impact on the healthcare landscape. This collaborative approach positions HIC as a significant player in the pediatric healthcare investment space.

Andrew M. Meadow - Founding Partner. Andrew has extensive experience in venture capital and healthcare investments, focusing on pediatric innovations.

Nicole J. Walker - Venture Partner, Investment Committee. Nicole brings a wealth of knowledge in healthcare strategy and investment.

Arlene Ruiz de Luzuriaga, MD, MPH, MBA - Investment Committee. Arlene is a medical doctor with expertise in public health and business administration.

Tricia L. Schumann - Principal. Tricia has a strong background in healthcare investments and operational support for startups.

John Ellis, MD - Senior Advisor, Investment Committee. John is a physician with significant experience in pediatric healthcare.

Jeff Kaplan, JD - Of Counsel - Non-Voting Investment Committee. Jeff provides legal expertise and guidance on investment matters.

Jamil Dihu, DO, MBA - Executive Director. Jamil has a background in medicine and business, focusing on healthcare innovation.

P. Zhen Chan, MD, MBA - Senior Associate. Zhen is involved in evaluating investment opportunities and supporting portfolio companies.

To pitch Health Innovation Capital, founders should visit their website at healthinnovation.vc. It is recommended to include a detailed deck that outlines the startup's mission, the problem it addresses in pediatric healthcare, and the management team's qualifications. HIC values clear communication of how the startup's innovations can improve patient outcomes.

Response times may vary, but founders should expect to hear back within a few weeks after submission. Warm introductions are preferred, especially from individuals within HIC's network or associated healthcare centers of excellence.

Health Innovation Capital offers a Venture Fellow Program designed for individuals from top institutions to gain exposure to venture capital while pursuing their education or careers. This program aims to build a community of diverse young venture capital executives focused on pediatric care.

Participants in the Venture Fellow Program receive mentorship and training, providing them with valuable insights into the venture capital industry and pediatric healthcare innovations.

In recent months, Health Innovation Capital has continued to expand its network by collaborating with over 30 healthcare centers of excellence in the U.S., Europe, and the Middle East. This collaboration enhances their ability to evaluate investment opportunities effectively.

Additionally, HIC's foundation has been active in donating a portion of its profits to support early-stage research and development in pediatric care, reinforcing their commitment to improving healthcare outcomes for children.